DexCom, Inc. (DXCM), a medical device company, said it has appointed Kevin Sayer, currently the company's president, as its chief operating officer or COO.
As President, Sayer is responsible for the firm's research and development, manufacturing, clinical, regulatory and finance functions. He will continue to lead these groups, and with the additional responsibility as COO, Sayer will also lead the company's sales, marketing, and other core commercial functions.
DexCom noted that Sayer will continue to report to Terry Gregg, chief executive officer of the company.
Sayer has served as DexCom's president since June 2011, and as a board member since November 2007.
For comments and feedback: editorial@rttnews.com